Results 21 to 30 of about 22,957 (173)

The occurrence of Borrelia miyamotoi in Dermacentor reticulatus and Ixodes ricinus ticks in the Chornobyl Exclusion Zone, Ukraine [PDF]

open access: yesScientific Reports
Borrelia miyamotoi spirochete is carried by Ixodidae ticks and causing Borrelia miyamotoi disease (BMD), a relapsing fever illness reported worldwide, often in the same geographic areas where Lyme disease is endemic.
Beata Fiecek   +6 more
doaj   +3 more sources

Characterization of a Borrelia miyamotoi membrane antigen (BmaA) for serodiagnosis of Borrelia miyamotoi disease [PDF]

open access: yesTicks and Tick-borne Diseases, 2020
Borrelia miyamotoi is a tick-borne pathogen that causes Borrelia miyamotoi disease (BMD), an emerging infectious disease of increasing public health significance. B. miyamotoi is transmitted by the same tick vector (Ixodes spp.) as B. burgdorferi sensu lato (s.l.), the causative agent of Lyme disease, therefore laboratory assays to differentiate BMD ...
Emma K, Harris   +6 more
europepmc   +4 more sources

Antigenic variation is caused by long plasmid segment conversion in a hard tick-borne relapsing fever Borrelia miyamotoi. [PDF]

open access: yesPLoS Pathogens
Borrelia miyamotoi is a hard tick-borne spirochete genetically related to relapsing fever Borrelia and the etiological agent of an emerging infectious disease in humans. Like relapsing fever Borrelia, B.
Tomohi Takeuchi   +4 more
doaj   +3 more sources

Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021 [PDF]

open access: yesEmerging Infectious Diseases, 2023
Infection with Borrelia miyamotoi in California, USA, has been suggested by serologic studies. We diagnosed B. miyamotoi infection in an immunocompromised man in California. Diagnosis was aided by plasma microbial cell–free DNA sequencing.
Luis Alberto Rubio   +9 more
doaj   +3 more sources

Evaluation of Immunocompetent Mouse Models for Borrelia miyamotoi Infection [PDF]

open access: yesMicrobiology Spectrum, 2023
Borrelia miyamotoi is a causative agent of hard tick relapsing fever, was first identified in the early 1990s, and was characterized as a human pathogen in 2011. Unlike other relapsing fever Borrelia species, B. miyamotoi spread by means of Ixodes ticks.
Brittany A. Armstrong   +3 more
semanticscholar   +4 more sources

Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi [PDF]

open access: yesMicrobiology Spectrum, 2022
This paper describes the protein array as a novel serological test for the diagnosis of Borrelia miyamotoi disease (BMD), by reporting the methodology, the development of a diagnostic algorithm, and its extensive validation.
Joppe W Hovius
exaly   +3 more sources

Nanopore sequencing identifies Borrelia miyamotoi as an unexpected cause of meningitis after B cell depletion [PDF]

open access: yesNeuropathol Appl Neurobiol
Neuropathology and Applied Neurobiology, Volume 50, Issue 6, December 2024.
Christine Anna Dambietz   +7 more
wiley   +3 more sources

Human Borrelia miyamotoi Infection, Austria [PDF]

open access: yesEmerging Infectious Diseases, 2020
We report a human case of Borrelia miyamotoi infection diagnosed in Austria. Spirochetes were detected in Giemsa-stained blood smears. The presence of B.
Selma Tobudic   +7 more
doaj   +4 more sources

Borrelia miyamotoi BipA-like protein, BipM, is a candidate serodiagnostic antigen distinguishing between Lyme disease and relapsing fever Borrelia infections

open access: yesTicks and Tick-Borne Diseases
A Borrelia miyamotoi gene with partial homology to bipA of relapsing fever spirochetes Borrelia hermsii and Borrelia turicatae was identified by a GenBank basic alignment search analysis.
Kevin S. Brandt   +3 more
doaj   +3 more sources

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe [PDF]

open access: yesEmerging Infectious Diseases, 2018
Borrelia miyamotoi disease is a hard tick–borne relapsing fever illness that occurs across the temperate climate zone. Human B. miyamotoi disease in immunocompetent patients has been described in Russia, North America, and Japan. We describe a case of B.
Dieuwertje Hoornstra   +4 more
doaj   +6 more sources

Home - About - Disclaimer - Privacy